Treating Multiple Myeloma in Latin America and Canada

Emerging and Practical Concepts in Multiple Myeloma


In recent years, progress in the understanding of multiple myeloma has led to novel therapies that are rapidly changing treatment paradigms. Aptitude Health developed the Global Multiple Myeloma Academy to help physicians who treat multiple myeloma bridge the gap between innovation and implementation of patient care.

Date and Location

18–19 June 2021, Virtual Meeting

Meeting Content

View the slides and watch the video of Day 1

Meeting Content

View the slides and watch the video of Day 2


Rafael Fonseca

Rafael Fonseca, MD

Mayo Clinic Cancer Center, USA

Irene Ghobrial

Irene Ghobrial, MD

Dana-Farber Cancer Institute, USA

Vania Tietsche de Moraes Hungria

Vania Hungria, MD, PhD

São Germano Clinic, São Paulo, Brazil

Humberto Martínez Cordero

Humberto Martínez Cordero, MD

National Cancer Institute, Bogotá, Colombia

María-Victoria Mateos, MD, PhD

María-Victoria Mateos, MD, PhD

University of Salamanca, Spain

Natalia Paola Schütz

Natalia Schütz, MD, MS

Instituto Universitario del Hospital Italiano de Buenos Aires, Argentina

Keith Stewart

Keith Stewart, MD

Princess Margaret Cancer Centre, Canada

Jorge Vela-Ojeda

Jorge Vela-Ojeda, MD, PhD

Hospital de Especialidades CMN La Raza, IMSS, Mexico City, Mexico


This virtual program was held over 2 days.
Day 1: Minimal Residual Disease, Frontline Therapies, and the Role of Transplantation
Day 2: Management of High-Risk, Relapsed, and Heavily Pretreated Multiple Myeloma, New and Future Therapies, and Patient Case Discussion

Day 1: Friday, June 18, 2021

6.00 PM – 8.45 PM Rio time (UTC-3)

Time (UTC -3) Topic Speaker
6.00 PM – 6.15 PM Welcome and Meeting Overview Rafael Fonseca
6.15 PM – 6.35 PM Smoldering Multiple Myeloma
• Diagnosis, criteria, and when and how to intervene
Irene Ghobrial
6.35 PM – 6.55 PM Role of Minimal Residual Disease in Multiple Myeloma
• Prognostic value, clinical relevance, and MRD-driven therapeutic guidance
Rafael Fonseca
6.55 PM – 7.15 PM Frontline Therapy for Newly Diagnosed Transplant-Eligible Multiple Myeloma: The Role of Transplantation
• Guidelines, induction therapies, and how and when to transplant
Vania Hungria
7.15 PM – 7.30 PM Break  
7.30 PM – 7.50 PM Optimal Use of Consolidation and Maintenance Therapy
• Evolving insights in consolidation and maintenance treatment after transplant
Jorge Vela-Ojeda
7.50 PM – 8.15 PM Frontline Therapy for Newly Diagnosed Transplant-Ineligible Patients
• Criteria, guidelines, and treatment choices
Keith Stewart
8.15 PM – 8.30 PM Patient Case Discussion: Newly Diagnosed + Relapsed/Refractory Multiple Myeloma Eloísa Riva
8.30 PM – 8.45 PM Session Close Rafael Fonseca

Day 2: Saturday, June 19, 2021

6.00 PM – 9.30 PM Rio time (UTC-3)

Time (UTC-3) Topic Speaker
6.00 PM – 6.10 PM Session Open Rafael Fonseca
6.10 PM – 6.30 PM Identification and Special Considerations for High-Risk Multiple Myeloma
• Risk stratification, prognosis, and treatment choices
María-Victoria Mateos
6.30 PM – 6.55 PM Management of Early Relapse of Multiple Myeloma
• Definition, prognosis, and treatment choices
Rafael Fonseca
6.55 PM – 7.20 PM Management of Heavily Pretreated Multiple Myeloma
• Optimal use of treatment choices in relapsed/refractory multiple myeloma, excluding T-cell engagers
Keith Stewart
7.20 PM – 7.30 PM Break  
7.30 PM – 8.20 PM New and Future Therapies for Multiple Myeloma
• Promising new developments in relapsed/refractory MM
• Latest trial updates and upcoming new strategies; focus on BCMA-directed therapies
Irene Ghobrial
8.20 PM – 9.15 PM Patient Case Discussion: Relapsed/Refractory Multiple Myeloma
• Cases from the region will be discussed with the faculty – “tumor board approach”
• Relapsed/refractory MM, treatment challenges in the region – Natalia Schütz (Arg)
‒ Case 1: Cristian Seehaus and Natalia Schütz (Arg)
‒ Case 2: Ana Luiza Miranda Silva Días and Vania Hungria (Bras)
‒ Case 3: Didier Larios Sanjuan and Humberto Martínez-Cordero (Col)
‒ Case 4: Sofía Sánchez and Jorge Vela-Ojeda (Mex)
All faculty
9.15 PM – 9.30 PM Session Close Rafael Fonseca